Previous 10 | Next 10 |
Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015. With only a few minor exceptions, this is true for most companies, especially the ph...
In a statement , FDA Commissioner Scott Gottlieb, M.D. says the agency has submitted its request for $6.1B in funding for fiscal 2020, an increase of $643M from this fiscal year. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla ...
Effective in June, Health Canada will institute new regulations related to the marketing of Class B opioids, a class of painkillers equal to or stronger than morphine. More news on: Endo International plc, INSYS Therapeutics, Inc., Titan Pharmaceuticals, Inc., Healthcare stocks news, ...
I had last covered Mallinckrodt ( MNK ) in August 2018 , when the company was trading closer to the $34 levels. I had recommended the company as a buying opportunity, but the market proved me completely wrong. However, even after failing once, I am daring to recommend this stock in March 20...
In June of 2015, I started a series of articles in which I highlight the stocks from the Dividend Champions list that have the highest and the lowest Percent Above Average Yield (PAAY) over the past year and over the past five years. PAAY is a measure of how much a stock is above (high PAAY, u...
DUBLIN , March 5, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that Endo Pharmaceuticals Inc. initiated patent litigation on March 1, 2019 in the United States District Court for the District of Delaware regarding Perrigo's Paragraph IV Abbreviate...
The broad market's down day notwithstanding, opioid drugmakers are under modest pressure in apparent response to a report that privately held Purdue Pharma is mulling a Chapter 11 bankruptcy filing to protect itself from the ~2,000 lawsuits against it related to its marketing practices for...
NEW YORK, NY / ACCESSWIRE / March 3, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronst...
The following slide deck was published by Perrigo Company in conjunction with their 2018 Q4 earnings Read more ...
Perrigo Company (PRGO) Q4 2018 Results Earnings Conference Call February 27, 2019 04:30 PM ET Company Participants Bradley Joseph - VP, Global IR Ron Winowiecki - CFO Murray Kessler - President & CEO Conference Call Participants Louise Chen - Cantor Fitzgerald Chri...
News, Short Squeeze, Breakout and More Instantly...
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024 PR Newswire DUBLIN , July 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its secon...
2024-07-19 06:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business PR Newswire DUBLIN , July 10, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that it has compl...